Alpha 2.0
Login Register
» Authors » B Vogelstein

B Vogelstein

Explore the profile of B Vogelstein including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 310
Citations 68660
Followers 0
Related Specialties
Science
Oncology
Cell Biology
Top 10 Co-Authors
K W Kinzler
S R Hamilton
E R Fearon
C Lengauer
J K WILLSON
S E Kern
S H Bigner
N Papadopoulos
S Markowitz
K R Cho
Published In
Cancer Res
Proc Natl Acad Sci U S A
Science
Nature
Cell
Affiliations
Soon will be listed here.
Recent Articles
1.
Erratum to "Annotated normal CT data of the abdomen for deep learning: Challenges and strategies for implementation" [Diagn. Interv. Imaging. 101 (2020) 35-44]
Park S, Chu L, Fishman E, Yuille A, Vogelstein B, Kinzler K, et al.
Diagn Interv Imaging . 2020 May; 101(6):427. PMID: 32446597
No abstract available.
2.
Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features
Park S, Chu L, Hruban R, Vogelstein B, Kinzler K, Yuille A, et al.
Diagn Interv Imaging . 2020 Apr; 101(9):555-564. PMID: 32278586
Purpose: The purpose of this study was to determine whether computed tomography (CT)-based machine learning of radiomics features could help distinguish autoimmune pancreatitis (AIP) from pancreatic ductal adenocarcinoma (PDAC). Materials...
3.
Deep lessons learned: Radiology, oncology, pathology, and computer science experts unite around artificial intelligence to strive for earlier pancreatic cancer diagnosis
Weisberg E, Chu L, Park S, Yuille A, Kinzler K, Vogelstein B, et al.
Diagn Interv Imaging . 2019 Oct; 101(2):111-115. PMID: 31629672
No abstract available.
4.
Annotated normal CT data of the abdomen for deep learning: Challenges and strategies for implementation
Park S, Chu L, Fishman E, Yuille A, Vogelstein B, Kinzler K, et al.
Diagn Interv Imaging . 2019 Jul; 101(1):35-44. PMID: 31358460
Purpose: The purpose of this study was to report procedures developed to annotate abdominal computed tomography (CT) images from subjects without pancreatic disease that will be used as the input...
5.
Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
Lee B, Lipton L, Cohen J, Tie J, Javed A, Li L, et al.
Ann Oncol . 2019 Jun; 30(9):1472-1478. PMID: 31250894
Background: In early-stage pancreatic cancer, there are currently no biomarkers to guide selection of therapeutic options. This prospective biomarker trial evaluated the feasibility and potential clinical utility of circulating tumor...
6.
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
Tie J, Kinde I, Wang Y, Wong H, Roebert J, Christie M, et al.
Ann Oncol . 2015 Apr; 26(8):1715-22. PMID: 25851626
Background: Early indicators of treatment response in metastatic colorectal cancer (mCRC) could conceivably be used to optimize treatment. We explored early changes in circulating tumor DNA (ctDNA) levels as a...
7.
Activation of PI3Kα by physiological effectors and by oncogenic mutations: structural and dynamic effects
Gabelli S, Echeverria I, Alexander M, Duong-Ly K, Chaves-Moreira D, Brower E, et al.
Biophys Rev . 2014 Oct; 6(1):89-95. PMID: 25309634
PI3Kα, a heterodimeric lipid kinase, catalyzes the conversion of phosphoinositide-4,5-bisphosphate (PIP) to phosphoinositide-3,4,5-trisphosphate (PIP), a lipid that recruits to the plasma membrane proteins that regulate signaling cascades that control key...
8.
Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia
Zhang X, Reis M, Khoriaty R, Li Y, Ouillette P, Samayoa J, et al.
Leukemia . 2011 Jun; 25(12):1908-10. PMID: 21701494
No abstract available.
9.
Absence of germline prohibitin mutations in early-onset breast-cancer
Tokino T, Davidson N, Helzlsouer K, Zehnbauer B, Nakamura Y, Vogelstein B, et al.
Int J Oncol . 2011 May; 3(4):769-72. PMID: 21573431
The prohibitin gene, mapped to chromosome 17q21 is a candidate tumor suppressor gene. Because several somatic mutations of prohibitin were detected in breast tumors, we sought to identify potential carriers...
10.
Similarity of the DNA-damage responsiveness and growth-suppressive properties of waf1/cip1 and gadd45
Zhan Q, Eldeiry W, Bae I, Alamo I, Kastan M, Vogelstein B, et al.
Int J Oncol . 2011 May; 6(5):937-46. PMID: 21556622
The cellular responses to genotoxic stress are complex involving both p53-dependent and independent mechanisms. In the case of the GADD genes, many stresses eliciting growth arrest have been shown to...